Compassionate useMitochondrial Peptide
Compound 62033
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-062033
Risk Class
HIGH
Last Audit
Dec 2, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Compound 62033 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for oncology adjuvant and inflammation control.
The dossier currently sits in compassionate use with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-062033 with updates logged 2108-12-02.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Oncology adjuvantInflammation control
Nomenclature
CX-62033Mitochondrial Peptide Program 62033
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-062033
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-62033